The purpose of this study is to determine the free tissue kinetics of ertapenem and meropenem in fatty tissue and intraperitoneal fluid up to 24 hours after administration of the IMP.
Tissue kinetics of ertapenem and meropenem in fatty tissue, intraperitoneal fluid and plasma.